Background: An important issue in autoimmune dis-
INTRODUCTION
The ability of MHC class II molecules to bind and display fragments of proteins on the surface of antigen-presenting cells both selects the T cell repertoire in the thymus and determines which CD4+ T cell clones are expanded or anergized in the periphery (1) . A detailed understanding of the molecular basis of peptide binding to These principles are likely to hold for other human and murine MHC class II proteins, primarily because many of the residues shown to form hydrogen bonds to the peptide ligands in the HLA-DRB 1*0101 crystal are conserved in most isotypes and alleles (3, 8, 9) . However, the chemical composition and topology of the binding site will vary depending on the sequence of the class II protein.
I-Au confers susceptibility to experimental allergic encephalomyelitis (EAE), which is a possible animal model for multiple sclerosis (MS) (10, 11) . Previous studies have defined the amino-terminal 11 amino acids of myelin basic protein (MBP Ac 1-11) to be both immunodominant and encephalitogenic in H-2u mice (12) . Some of the amino acids interacting with the class II protein and the T cell receptor have been defined by assaying a variety of structural analogs of MBP Ac 1-11 in T cell proliferation and qualitative cell surface binding assays (13, 14) .
To investigate whether there is a correlation between the ability of MBP-derived peptides to bind I-AU and their capacity to induce EAE in mice of the H-2u haplotype, the apparent affinity of a number of peptides of myelin basic protein and other proteins has been determined.
MATERIALS AND METHODS

Purification of I-AU Proteins
The procedures used for detergent solubilization and affinity purification of I-AU molecules from the cell line (kindly provided by Dr. D. Zaller), which expresses I-Au a-and I-Au 13-chains, were similar to those described previously by Babbitt et al. (15) .
Binding and Inhibition Assays For direct binding assays, an optimal concentration of affinity-purified I-Au (35 nM) was incubated with serial dilutions of an ovalbumin peptide corresponding to residues 323-339 modified with long-chain biotin at the amino terminus (NLCB ova 323-339) in phosphate-buffered saline containing 0.02% dodecyl maltoside, pH 5.5, in 96-well polypropylene plates (Costar, Cambridge, MA, U.S.A.) for 16-20 h at 370C. In studies optimizing the assay, only between 5 and 10% of the I-Au molecules were capable of binding added peptide. Therefore, the effective concentration of I-Au was approximately 3.5 nM. Peptides were synthesized using solid-phase techniques (18) , either using an Applied Biosystems Peptide synthesizer or an Advanced Chemtech robotics system utilizing FastMOC chemistry with commercially available Wang resins, and Fmoc protected amino acids as previously described (6) . All peptides were purified using reverse-phase HPLC and their structures were confirmed by amino acid analysis and fast atom bombardment mass spectrometry.
RESULTS
Design of Binding and Inhibition Assays
Detergent solubilized and affinity purified I-AU was incubated with varying concentrations of a peptide corresponding to residues 323-339 of hen egg ovalbumin modified at the amino terminus with long-chain biotin. The amount of specific complexes were quantitated by addition of europium-labeled streptavidin, and measuring the resultant fluorescence. The concentration of agonist that resulted in the half-maximal signal (ED50) was 10 nM (Fig. IA) . Consistent with a variety of other binding studies of MHC class II proteins, only 6% of the I-AU molecules bound this peptide.
To convert the direct binding assay into a competitive assay using unlabeled antagonists, a sufficiently low concentration of the biotinylated agonist was chosen and incubated with varying concentrations of unlabeled ovalbumin peptide with affinity-purified I-AU. After capture and detection of the complexes on microtiter plates, the half-maximal signal (IC50) of the resultant inhibition curve was identical, within experimental error, to the ED50 (Fig. 1B) . Because the IC50 was equivalent to the ED50 value, the measured IC50 Peptide Concentration (gM) Table 2 . In all cases, the sequences contained either a hydrophobic amino acid followed by a basic residue, or a pair of hydrophobic amino acids, separated by one amino acid from either alanine, serine, or threonine. When the relative position and composition of these amino acids were compared with the sequence of a well-studied peptide, known to bind I-Au, Ac 1-11 of myelin basic protein, an interesting similarity was seen. In MBP Ac 1-11, substitution of lysine at the fourth position with alanine generated more potent analogs when assayed by T cell recognition, cellular inhibition assays, and qualitative binding assays (13, 14) . Analogs containing a tyrosine at this position bound I-AU even better (10) . This was confirmed when these analogs were assayed using the fluorescent binding assay. The natural sequence, Ac 1-11, bound I-AU poorly, exhibiting an IC50 value close to 100 ,uM ( Only when the peptide was reduced to six amino acids was detectable inhibition lost. A slightly different pattern of IC50 values was seen for peptides of varying lengths containing alanine or tyrosine at the fourth position. In the former case, the IC50 values increased as the peptides were shortened from 11 down to seven amino acids, consistent with the additional peptide bonds making contacts with the binding site that increased affinity. In contrast, analogs containing tyrosine at the fourth residue bound I-AU equivalently regardless of whether the peptide was eleven, eight, or seven amino acids in length. Evidently, the presence of the tyrosine compensated for the loss of the contacts provided by the carboxyl-terminal amino acids. The a-carboxyl group was beneficial for binding, because replacement with an amide resulted in a 5-fold increase in the IC50 value (Table 5 ). An acetylated heptamer, containing eight peptide bonds, a tyrosine at the fourth, arginine at the fifth, and alanine at the seventh position, bound I-AU with an IC50 value of 60 nM, providing support that these characteristics were the minimal requirements for high-affinity binding.
DISCUSSION
The first unusual aspect of this investigation was that when a set of peptides corresponding to much of the sequence of rat myelin basic protein was assayed for binding to (22) .
As an initial step in understanding the biochemical basis of this paradox, which presumably involves details of antigen processing, establishment of the T cell repertoire, and T cell tolerance, the structural details of I-Au:peptide interactions were explored. A detailed knowledge of the requirements for the formation of I-AU:peptide complexes is a prerequisite for the investigation of the more complex biological mechanisms involved in the biological and chemical basis of immunogenicity of autoantigens.
Comparison of the primary sequences of the peptides that bound I-AU with low IC50 values revealed a loose motif of either a pair of hydrophobic amino acids or a hydrophobic followed by a positively charged residue separated from a small amino acid by one position. This pattern was consistent with the previously reported beneficial substitution of either an alanine or a tyrosine for a lysine in MBP Ac 1-11 (10, 13) . When the analogs with alanine substituted for each amino acid in this sequence were assayed for binding to I-AU, only substitutions at the fourth and fifth residues significantly increased the affinity of the peptide.
The importance of these three amino acids was supported further by substitution of these residues into simplified polymers of alanine. This backbone hides the importance of a small amino acid at the second and seventh position, but the observed low IC50 values of these simplified peptides verified the importance of these sidechains in binding. However, their position in the polyalanine backbone relative to the charged amino and carboxyl termini did not appear to be critical, indicating that shorter analogs will also bind with high affinity. Low IC50 values were observed for analogs as short as seven amino acids. In each of the sets of peptides, analogs containing tyrosine bound better than those with alanine, which in turn bound better than peptides containing lysine, providing strong evidence that in all cases the peptides were located in equivalent position in the binding site with the fourth amino acid contacting the identical subsite regardless of the length of the peptide. The demonstration that MBP Ac 1-7 could stimulate an I-A'-restricted T cell hybridoma specific for MBP Ac 1-11 (20) further supports this premise. Data in this paper also emphasize that the important sidechain contacts dictate the register of binding, regardless of whether they are in the context of autoantigenic determinant or a simplified polyalanine peptide.
The observation that the immunodominant and principal encephalitogenic determinant of MBP, Ac 1-11, binds I-A' with an IC50 value greater than 100 ,uM is consistent with the theory that autoreactive T cell clones escape tolerance induction because of their relative low binding affinity for the MHC class II protein (24) . In contrast, T cell clones specific for regions of MBP that bind I-AU well, such as residues [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and 142-167, should be tolerized. However, recent experiments have shown that H-2u mice are not tolerant to 11-23 and 142-167, but also that these regions of MBP are nonencephalitogenic and appear to be processed less efficiently from the intact protein than Ac 1-11 (L. Fugger and H. 0. McDevitt, unpublished data). Furthermore, the amino terminal acetyl group of Ac 1-11, may make this peptide less susceptible to exopeptidases than other MBP-derived peptides. Consequently, the local concentration of Ac 1-11 at the site(s) where I-Au:peptide complexes are formed may be far greater than other MBP peptides with higher apparent affinity. These complexes are most likely recognized by T cell receptors with both high specificity and affinity, because a hexamer containing only five of the native residues in the parent MBP Ac 1-11 is encephalitogenic (20) . Therefore, the molecular basis for why a low-affinity peptide such as MBP Ac 1-11 is the immunodominant and principal disease-inducing epitope in MBP, might be a combination of efficient processing of this determinant from MBP and the induction of clones expressing T cell receptors with extraordinarily high affinity for the I-Au:MBP Ac 1-1I complex.
